Articles tagged with “gilead-sciences”

Hepcludex FDA Approval: First Treatment for Hepatitis D

Review the FDA accelerated approval of Hepcludex (bulevirtide) for chronic hepatitis delta virus (HDV), including clinical trial data and public health impact.

40 min read

5/9/2026

hepcludex bulevirtide hepatitis delta virus hdv treatment fda approval viral hepatitis gilead sciences liver disease

Gilead-Tubulis $5B Acquisition: ADC Oncology Strategy

Analyze Gilead's $5 billion acquisition of Tubulis, examining antibody-drug conjugate (ADC) oncology strategy, market trends, and new clinical platforms.

40 min read

4/17/2026

antibody-drug conjugates gilead sciences tubulis oncology strategy pharma acquisitions targeted cancer therapy adc market trends